Pharmaron Beijing Co., Ltd. Class H(DE:17Q1)
€3.38+0.04 (+3.05%)
DE:17Q1
Pharmaron Beijing Co., Ltd. Class H ownership
€3.38
At close:+0.04 (+3.05%)
Pharmaron Beijing Co., Ltd. Class H (17Q1) Ownership - Who Owns Pharmaron Beijing Co., Ltd. Class H?
0 Followers
Pharmaron Beijing Co., Ltd. Class H (17Q1) Ownership Overview
- 5.69% Mutual Funds
- 4.20% ETFs
- 90.12% Public Companies and Individual Investors
The ownership structure of Pharmaron Beijing Co., Ltd. Class H (DE:17Q1) stock is a mix of institutional, retail, and individual investors. Approximately 9.88% of the company’s stock is owned by Institutional Investors, and 90.12% is owned by Public Companies and Individual Investors.
The ownership structure of Pharmaron Beijing Co., Ltd. Class H (DE:17Q1) stock is a mix of institutional, retail, and individual investors. Approximately 9.88% of the company’s stock is owned by Institutional Investors, and 90.12% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 11,746,977 | Institution | 3.26% | 44,051,164 |
| Vanguard International Equity Index Funds | 6,178,073 | Institution | 1.72% | 23,167,774 |
| Vanguard Star Funds | 5,120,370 | Institution | 1.42% | 19,201,388 |
| Old Westbury Funds Inc | 3,880,919 | Institution | 1.08% | 14,553,446 |
| Dfa Investment Dimensions Group Inc | 2,826,800 | Institution | 0.79% | 10,600,500 |
| Ariel Investment Trust | 859,800 | Institution | 0.24% | 3,224,250 |
| Dimensional | 703,025 | Institution | 0.20% | 2,636,344 |
| Jpmorgan | 682,220 | Institution | 0.19% | 2,558,325 |
| T. Rowe Price International Funds, Inc. | 564,800 | Institution | 0.16% | 2,118,000 |
| John Hancock Variable Insurance Trust | 435,900 | Institution | 0.12% | 1,634,625 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard International Equity Index Funds | 6,178,073 | Institution | 1.72% | 23,167,774 |
| Vanguard Star Funds | 5,120,370 | Institution | 1.42% | 19,201,388 |
| Old Westbury Funds Inc | 3,880,919 | Institution | 1.08% | 14,553,446 |
| Dfa Investment Dimensions Group Inc | 2,826,800 | Institution | 0.79% | 10,600,500 |
| Ariel Investment Trust | 859,800 | Institution | 0.24% | 3,224,250 |
| T. Rowe Price International Funds, Inc. | 564,800 | Institution | 0.16% | 2,118,000 |
| John Hancock Variable Insurance Trust | 435,900 | Institution | 0.12% | 1,634,625 |
| Fidelity Salem Street Trust | 385,175 | Institution | 0.11% | 1,444,406 |
| John Hancock Funds Ii | 212,800 | Institution | 0.06% | 798,000 |
| American Century Etf Trust | 5,850 | Institution | <0.01% | 21,938 |
FAQ
What percentage of Pharmaron Beijing Co., Ltd. Class H (DE:17Q1) stock is held by institutional investors?
According to the latest TipRanks data, approximately 9.88% of Pharmaron Beijing Co., Ltd. Class H (DE:17Q1) stock is held by institutional investors: 5.69% by mutual funds and 4.20% by ETFs.
What percentage of Pharmaron Beijing Co., Ltd. Class H (DE:17Q1) stock is held by retail investors?
According to the latest TipRanks data, approximately 90.12% of Pharmaron Beijing Co., Ltd. Class H (DE:17Q1) stock is held by public companies and individual investors.
Who owns the most shares of Pharmaron Beijing Co., Ltd. Class H (DE:17Q1)?
Vanguard owns the most shares of Pharmaron Beijing Co., Ltd. Class H (DE:17Q1).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
